3 Australian Growth Stocks With Earnings Growth Over 14%

Global bond yields are surging and borrowing costs are climbing, which puts pressure on heavily indebted businesses and rewards companies that can fund themselves internally. That is where fast growing Australian stocks with committed insider owners come in, because leadership teams with real capital at stake often focus tightly on disciplined expansion and cash use. This article highlights three such high growth, high ownership opportunities from our screener.

The three stocks covered below are just a starter pack from this theme, while the full screen surfaced 112 more companies with similarly strong growth stories and insider alignment that are not unpacked here. If you want to identify your own highest conviction ideas, go straight to the Fast Growing Stocks With High Insider Ownership screener to filter and analyze the full list on your terms.

Telix Pharmaceuticals (ASX:TLX)

Overview: Telix Pharmaceuticals develops and commercialises precision radiopharmaceutical diagnostics and therapies for cancers, with its Precision Medicine and Therapeutics pipeline central to the growth story.

Operations: Telix generates about $705 million from Precision Medicine and $277 million from Manufacturing Solutions, with around $872 million coming from the United States.

Market Cap: A$5.4b

Telix Pharmaceuticals matters for this high-growth, high-insider-ownership theme because its cancer-focused precision imaging and therapy platform is already commercial, yet still early in its broader pipeline rollout, which is exactly where aligned management can materially influence how that potential is converted into durable results.

"Their primary revenue generating imaging agents: 'Illuccix' and 'Gozellix', are utilised in 23+ countries worldwide, including key markets such as the U.S, Europe, China and Japan, with revenue figures of $803.8m (USD) in the 2025 Financial Year (within their already upgraded guidance range) provided for FY25, a cash balance of $141.9m (USD), and the potential growth of Gozellix as its launch into the U.S expands."

For Telix, a single unresolved pressure on how quickly its therapeutic pipeline converts from trials to real-world use could reshape that growth trajectory.

If that timing risk matters to you, read the full narrative for Telix Pharmaceuticals to understand how Telix Pharmaceuticals management could accelerate or stall the next phase of its pipeline story.

Codan (ASX:CDA)

Overview: Codan designs and sells communications networks and metal detection products, with its DTC and Zetron communications platforms anchoring the growth-focused, insider-backed theme.

Operations: Codan generates about A$506 million from Communications and A$362 million from Metal Detection across customers in the United States, United Arab Emirates, and other regions.

Market Cap: A$12.1b

Codan matters for this fast-growth, high-insider-ownership screen because its Communications segment plugs directly into defense and public-safety demand, turning long-lived radio and dispatch systems into recurring upgrade and service contracts.

"Heightened geopolitical tensions, increased defense spending, and the need for resilient communications infrastructure, especially in light of remilitarization and growing demand for unmanned systems, are expanding Codan's customer base and forward order book in defense and public safety."

What happens to margins and earnings if one crucial assumption about the durability of defense and public-safety upgrade cycles quietly shifts?

Margins are only part of the story, and the full narrative for Codan shows how Codan's defense exposure, product mix and insider alignment could be quietly resetting expectations.

Southern Cross Electrical Engineering (ASX:SXE)

Overview: Southern Cross Electrical Engineering provides electrical, communications, security, fire and maintenance services across Australia, with renewable energy and energy management projects linking it to the fast growing decarbonization theme.

Operations: Southern Cross Electrical Engineering generates about A$718.7 million from electrical, security and communication services within Australia.

Market Cap: A$1.4b

Southern Cross Electrical Engineering matters for this fast growing, high insider ownership screen because its electrical and energy management expertise is now being applied to solar and wind projects, where long-lived infrastructure and ongoing maintenance can turn one-off builds into recurring, decarbonization-linked work.

"The company sits downstream of powerful structural drivers: AI workloads, cloud migration, enterprise digitalisation, and data sovereignty requirements, all of which are driving sustained demand for data centre capacity."

What happens to shareholder outcomes if one unseen pressure on how profitably that project backlog converts into cash shifts direction.

That cash conversion question is the crux, and the full narrative for Southern Cross Electrical Engineering lays out how Southern Cross Electrical Engineering could turn today's project queue into accelerating, longer term cash generation.

Seeking Fresh Alternatives Before They Fly

Fresh ideas move first, and the strongest breakouts often run before most investors even notice. Tap into curated momentum while it matters and before sentiment gets caught. Act now.

• Spot income workhorses built for staying power by scanning the 6 dividend fortresses before payout momentum cools and yields start dropping toward the crowd.
• Hunt early tech inflection points with the 92 AI infrastructure stocks while these backbone providers remain under the radar for now and institutional money is still building positions.
• Track the electrification ripple effect using the 16 top copper producer stocks so you catch potential production winners before fresh demand shocks fully reprice the sector.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com